학술논문
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
Document Type
Article
Author
Xu, Jianming; Kato, Ken; Raymond, Eric; Hubner, Richard A; Shu, Yongqian; Pan, Yueyin; Park, Sook Ryun; Ping, Lu; Jiang, Yi; Zhang, Jingdong; Wu, Xiaohong; Yao, Yuanhu; Shen, Lin; Kojima, Takashi; Gotovkin, Evgeny; Ishihara, Ryu; Wyrwicz, Lucjan; Van Cutsem, Eric; Jimenez-Fonseca, Paula; Lin, Chen-Yuan; Wang, Lei; Shi, Jingwen; Li, Liyun; Yoon, Harry H
Source
In The Lancet Oncology May 2023 24(5):483-495
Subject
Language
ISSN
1470-2045